Lundbeck
HLUN-B.CO
#2865
Rank
NZ$7.25 B
Marketcap
$7.55
Share price
7.19%
Change (1 day)
-4.85%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Earnings for Lundbeck (HLUN-B.CO)

Earnings in 2024 (TTM): NZ$0.92 Billion

According to Lundbeck 's latest financial reports the company's current earnings are NZ$3.18 Billion. , an increase over its 2023 earnings that were of NZ$0.74 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lundbeck from 2009 to 2024

Annual earnings

Year Earnings Change
2024 NZ$0.93 B25.46%
2023 NZ$0.74 B21.69%
2022 NZ$0.61 B31.79%
2021 NZ$0.46 B-4.53%
2020 NZ$0.48 B-45.08%
2019 NZ$0.88 B-33.97%
2018 NZ$1.33 B12.76%
2017 NZ$1.18 B94.32%
2016 NZ$0.61 B-136.98%
2015 -NZ$1.66 Billion-1258.1%
2014 NZ$0.14 B-72.43%
2013 NZ$0.51 B4.31%
2012 NZ$0.49 B-55.26%
2011 NZ$1.10 B6.64%
2010 NZ$1.03 B-6.68%
2009 NZ$1.11 B